The SLC6A4 polymorphism has also been associated with SSRI response to depression, and depressed patients with the SLC6A4 rs25531 LL genotype have been proven to respond better to fluoxetine than patients with other genotypes in the Indian population [77]. The gene discussed is SLC6A4; the disease is depressive symptom measurement.